Senate Finance Committee kicks off next week with a hearing to look at drug pricing, “Drug Pricing in America: A Prescription for Change, Part 1.” Testifiers on the list are:
- Peter Bach, MD, MAPP, Director at the Memorial Sloan Kettering Center for Health Policy and Outcomes,
- Doug Holtz-Eakin, President of the American Action Forum
- Mark Miller, PhD., Vice-President of Health Care at the Laura and John Arnold Foundation.
House Oversight and Reform Committee will also hold a hearing on Jan 29, “Prescription Drugs Price Increases.” next week on the prescription drug hikes announced earlier this month.